Pyrazolam #
| Common Nomenclature | Pyrazolam |
| Street & Reference Names | N/A |
| Reference Dosage | Light 1mg+; Common 2mg+; Strong 3mg+ [TripSit] |
| Anticipated: Onset / Duration | 15 Minutes / 6 Hours |
| Maximum Dose Experienced | 1mg |
| Form | Pill |
| RoA | Oral |
| Source / Jurisdiction | Internet / UK |
SUBJECTIVE EXPERIENCE #
Pyrazolam was developed during the 1970s at Hoffman-La Roche, and became widely available via the online markets circa 2012.
I originally purchased it as a potential sleep aid, but research, prior to consumption, revealed its true niche. It counters anxiety, and is active even at relatively small doses. I don’t suffer from undue social anxiety but I have tested it in a number of stressful situations. I have always been impressed.
Its strength for me is that whilst acting as an anxiolytic, it doesn’t cause drowsiness. It is functional, or at least has been every time I have sampled it.
It is one of only two benzodiazepines I have used on more than a couple of occasions (the other being etizolam).
In December 2016, despite the prior implementation of the Psychoactive Substances Act, pyrazolam and a number of other specifically named benzodiazepines were the subjects of a UK TCDO banning order, which made personal possession, and not just import and supply, illegal.